Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research

Published: Saturday, April 06, 2013
Last Updated: Friday, April 05, 2013
Bookmark and Share
Biologists working in life sciences and pharmaceutical research now have access via the Web to molecular data from Elsevier and from articles obtained from other leading publishers

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the launch of a web-based version of Pathway Studio, a research solution for biologists. Additionally, Pathway Studio now incorporates biological data from Elsevier’s biology journals in addition to journals obtained through collaboration with third-party publishers. The addition of this data to Pathway Studio results in a resource that is unparalleled in depth and coverage of molecular interactions with supporting evidence. The new web-based version broadly extends access to researchers to reveal new insights and to assist with critical decision making.

“Currently, molecular facts are scattered in individual articles and researchers must gather and integrate these to advance new discovery,” said Jaqui Mason, Product Development Director for Biology Products at Elsevier. “Pathway Studio presents these facts in a graphical context to help researchers assemble biological models that can be applied to target discovery programs, identify potential diagnostics, and reposition drugs. The new content included in Pathway Studio can expose a more complete picture in biology, which reduces risk, increases efficiency, and ultimately improves success rate whether it’s bringing a new drug to market or exploring a theory.”

“Incorporation of facts from Elsevier’s biology journals into Pathway Studio, as well as building a pipeline of fresh data through our collaboration with third-party publishers, enables us to deliver additional value to our portfolio of solutions across biology, chemistry, and medicine in order to better serve the needs of customers in early discovery and biology researchers,” said Mark van Mierle, Managing Director of Elsevier’s Pharma and Biotech Group. “Offering a web-based version of Pathway Studio has allowed us to streamline common tasks and make the benefit of this content accessible to a broader and more general user-base.”

The new web-based Pathway Studio adds additional early discovery capability to Elsevier’s suite of life science information solutions which include Reaxys, the leading chemistry discovery engine, PharmaPendium which supports regulatory and safety activities, TargetInsights, a biological literature search system for early discovery and Quosa, which automates literature management workflows with applications in pharmacovigilance and medical affairs. This suite effectively delivers complementary solutions spanning early discovery, pre-clinical, clinical and post-launch workflows.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biometrics Institute, Elsevier Partner for Biometrics 2014
The Biometrics Institute announce strategic partnership with Elsevier for the delivery of the Biometrics 2014 Conference & Exhibition to be held on the 21-23 October 2014 in London.
Wednesday, February 19, 2014
Elsevier Acquires Aureus Sciences
Elsevier purchases content assets including databases and information tools for pharmaceutical and biotech companies.
Thursday, January 24, 2013
A Risk Gene for Cannabis Psychosis
The ability of cannabis to produce psychosis has long been an important public health concern. This concern is growing in importance as there is emerging data that cannabis exposure during adolescence may increase the risk of developing schizophrenia.
Friday, November 16, 2012
New Protocols Improve Detection of MicroRNAs for Diagnosis
MicroRNAs (miRNAs) that regulate processes including fertilization, development, and aging show promise as biomarkers of disease. They can be collected from routinely collected fluids such as blood, saliva, and urine.
Monday, December 12, 2011
Elsevier Introduces Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
Elsevier’s lillumin8 combines scientific content from Elsevier and other publishers, web and patent content with intelligent web search technology.
Friday, January 23, 2009
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!